Novavax's Shot Effective Against Covid in Final Trial Analysis
This article was written by John Lauerman in Bloomberg:Novavax Inc.'s Covid-19 vaccine was 96.4% effective against mild, moderate and severe symptoms of the disease in the final analysis of a late-sta ...
12 Mar, 12:26
